Yoon et al. conducteda study where they deleted the A53T-SNCA gene using CRISPR/Cas9, whichsignificantly improved conditions related to PD, such as the overproductionof α-synuclein, reactive microgliosis, dopaminergic neurodegeneration,and PD-associated motor symptoms. This evidence concerns the gene SNCA and Parkinson disease.